Mdxhealth has been made aware that Amber Smith is fraudulently representing herself as a recruiter for mdxhealth. The job posting she is advertising is NOT legitimate. If Amber Smith reaches out to you via LinkedIn, please report the fraudulent account to LinkedIn. We apologize for the misrepresentation. We encourage you to check out our career page for a list of current positions available at mdxhealth.com
mdxhealth
Biotechnology Research
Irvine, CA 6,578 followers
Molecular Diagnostic Solutions for Prostate Cancer
About us
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.
- Website
-
https://mdxhealth.com/?utm_source=socialmedia&utm_medium=linkedin&utm_campaign=organicsocialtraffic
External link for mdxhealth
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Irvine, CA
- Type
- Public Company
- Founded
- 2003
- Specialties
- Molecular Diagnostics, Methylation, Cancer, Next Generation Sequencing, pharmaceutical and diagnostic products, and medical devices
Locations
-
Primary
15279 Alton Parkway Suite 100
Irvine, CA 92618, US
-
Rue d'Abhooz, 31
Herstal, Flanders 4040, BE
-
Harelbekestraat 72
3de verdieping, Gent 9000, BE
Employees at mdxhealth
Updates
-
Submitting your orders just got easier! With our Physician Portal you can order mdxhealth tests and access your patient reports online. Sign up here: https://ow.ly/bCvy50QTHk5
-
-
Have a safe and happy #IndependenceDay from mdxhealth!
-
-
Genomic Prostate Score (GPS) is a tissue-based test that can help: • Identify patients for active surveillance. • Inform treatment intensity for GS ≥4+3 and/or ≥pT3a cancer. Learn more: https://ow.ly/B6oI50QTE7V
-
-
Confirm mdx helps improve patient risk stratification so you can focus on finding aggressive prostate cancer. https://ow.ly/QbJO50QTCSJ
-
-
This Friday, June 21st, is Wear Blue Day! Wear blue to raise awareness about the importance of male health and to encourage men to live longer and healthier lives! #MensHealthMonth2024
-
Resolve mdx quickly identifies personalized antibiotic solutions for your patient’s UTI. Learn more: https://ow.ly/p45I50QTCOY
-